Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/23 17:15 | 9/14/23 | PALI | Health | BioPrd | Biological Products, (No Diag | Trenschel Robert J. | CA | D | S | 0 | 0.6400 | 0 | 0 | -100 | 0 | D | |||||||||||||||
11/16/15 19:40 | 11/16/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -27 | 1.09 | 0 | -25 | -3 | 826 | D | -56 | -61 | -36 | -17 | -15 | -1 | -10 | -3 | -1 | 2 | -6 | -25 | -70 | -75 |
11/9/15 20:17 | 11/9/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -30 | 1.18 | 0 | -25 | -3 | 851 | D | -51 | -58 | -37 | -11 | -27 | -6 | 4 | -9 | -8 | -10 | -10 | -42 | -76 | -83 |
11/3/15 19:11 | 11/2/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -29 | 1.17 | 0 | -25 | -3 | 876 | D | -46 | -56 | -31 | -22 | -22 | -5 | -2 | 8 | -5 | -5 | -12 | -31 | -76 | -85 |
10/27/15 16:38 | 10/26/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -28 | 1.13 | 1 | -25 | -3 | 901 | D | -52 | -60 | -40 | -36 | -26 | -13 | -14 | -11 | 10 | 17 | 9 | -32 | -36 | -67 |
10/19/15 17:14 | 10/19/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -31 | 1.23 | 1 | -25 | -3 | 926 | D | -52 | -61 | -38 | -30 | -16 | -23 | -4 | -4 | -2 | -2 | -12 | -53 | -40 | -78 |
10/13/15 18:49 | 10/12/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -33 | 1.31 | 1 | -25 | -3 | 951 | D | -50 | -56 | -43 | -25 | -10 | -16 | 6 | 3 | 1 | -2 | -11 | -19 | -40 | -72 |
10/5/15 18:27 | 10/5/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -31 | 1.26 | 1 | -25 | -2 | 976 | D | -52 | -62 | -33 | -34 | -11 | -14 | -18 | -9 | -2 | 4 | -6 | -20 | -46 | -78 |
9/28/15 20:45 | 9/28/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -41 | 1.64 | 1 | -25 | -2 | 1,001 | D | -28 | -45 | -10 | -10 | 37 | 24 | 20 | 16 | -13 | -18 | -27 | -23 | -46 | -70 |
9/21/15 21:24 | 9/21/15 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -38 | 1.52 | 0 | -25 | -2 | 1,026 | D | -41 | -52 | -35 | -17 | 15 | 4 | 5 | 5 | 3 | 19 | -17 | -29 | -42 | -76 |
9/3/14 18:54 | 9/2/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -25 | 4.09 | 2 | -6 | -1 | 496 | D | 675 | 137 | 9 | -10 | 24 | 22 | 19 | 4 | -4 | -6 | -19 | -31 | -6 | -60 |
8/4/14 18:18 | 8/1/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -17 | 2.78 | 3 | -6 | -1 | 484 | D | 210 | 95 | -9 | -13 | -32 | -12 | -9 | -4 | 1 | 5 | 29 | -10 | -3 | -51 |
7/1/14 16:33 | 7/1/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -25 | 4.17 | 5 | -6 | -1 | 490 | D | 396 | 183 | 57 | 1 | 21 | -3 | 0 | -6 | -4 | -15 | -23 | -13 | -33 | -49 |
6/2/14 16:01 | 6/2/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -26 | 4.25 | 3 | -6 | -1 | 496 | D | 357 | 205 | 62 | 20 | 13 | 37 | 16 | 6 | 4 | 4 | -3 | -8 | -34 | -66 |
5/5/14 16:00 | 5/1/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -21 | 3.54 | 5 | -6 | -1 | 502 | D | 248 | 188 | 53 | 5 | -19 | -13 | -16 | -8 | -3 | -10 | 29 | -14 | -18 | -47 |
4/23/14 16:03 | 4/22/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -30 | 4.25 | 6 | -7 | 0 | 1,489 | I | 313 | 273 | 77 | 23 | 16 | 0 | 3 | 12 | -1 | -9 | -9 | -21 | -34 | -51 |
4/2/14 19:10 | 4/1/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -25 | 4.11 | 5 | -6 | -1 | 526 | D | 293 | 282 | 56 | 44 | 27 | 14 | 0 | 13 | 0 | -3 | -20 | -10 | -27 | -61 |
3/21/14 16:14 | 3/20/14 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -24 | 4.04 | 4 | -6 | -1 | 532 | D | 297 | 297 | 72 | 88 | 48 | 29 | 26 | 5 | -2 | -11 | -5 | 0 | -22 | -40 |
11/7/13 16:02 | 10/21/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -23 | 2.35 | 2 | -10 | -1 | 685 | D | 82 | 125 | 80 | 52 | -15 | -4 | -4 | 6 | 5 | 7 | 9 | 36 | 35 | 19 |
10/21/13 13:28 | 10/18/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -24 | 2.44 | 3 | -10 | -1 | 695 | D | 83 | 107 | 111 | 46 | 10 | -11 | -4 | -4 | -4 | -5 | -1 | 44 | 77 | 11 |
9/23/13 16:02 | 9/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -26 | 2.62 | 4 | -10 | -1 | 705 | D | 70 | 84 | 128 | 63 | 65 | 52 | 18 | -5 | -4 | 15 | -7 | 2 | 65 | 31 |
9/19/13 16:38 | 9/19/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -26 | 2.61 | 4 | -10 | -1 | 715 | D | 87 | 133 | 131 | 86 | 69 | 65 | 22 | -1 | 0 | -3 | -3 | -5 | 76 | 26 |
8/21/13 20:37 | 8/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -31 | 1.55 | 1 | -20 | -3 | 725 | D | 38 | 227 | 36 | 12 | -6 | 1 | 3 | 8 | 2 | 1 | 61 | 49 | 112 | 122 |
7/22/13 16:02 | 7/22/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -21 | 1.62 | 1 | -13 | -2 | 745 | D | 9 | 66 | 23 | 48 | 11 | 10 | -4 | -2 | -3 | -6 | -6 | 51 | 112 | 101 |
6/21/13 15:07 | 6/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -18 | 1.40 | 1 | -13 | -2 | 758 | D | -1 | 61 | 22 | 26 | 8 | -7 | -7 | 0 | 11 | -2 | 15 | 81 | 75 | 211 |
6/11/13 18:46 | 6/7/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -9 | 1.42 | 1 | -6 | -3 | 202 | I | 38 | 68 | 29 | 31 | 26 | 6 | 9 | 6 | -1 | -7 | 11 | 43 | 66 | 186 |
5/21/13 15:53 | 5/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -19 | 1.51 | 1 | -13 | -2 | 771 | D | 6 | 54 | 51 | 24 | 39 | 22 | 10 | 12 | -1 | -3 | -1 | 7 | 69 | 157 |
4/23/13 12:40 | 4/22/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -15 | 1.13 | 0 | -13 | -2 | 783 | D | -34 | 11 | -2 | -12 | -3 | 3 | 4 | -1 | 1 | 6 | 25 | 44 | 111 | 273 |
3/22/13 14:13 | 3/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -15 | 1.14 | 0 | -13 | -2 | 796 | D | -36 | -1 | -14 | -3 | -10 | 6 | -3 | -1 | 0 | -1 | 1 | 26 | 127 | 275 |
2/26/13 17:48 | 2/25/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Garr Richard | MD | DO | CEO | S | -14 | 1.15 | 0 | -12 | -5 | 213 | I | -41 | -4 | 96 | 8 | -10 | -12 | -6 | -5 | 1 | 1 | 3 | 26 | 54 | 216 |
2/21/13 14:19 | 2/20/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -15 | 1.18 | 0 | -13 | -2 | 809 | D | -41 | 2 | 141 | 19 | -11 | -7 | -6 | -2 | -2 | -5 | -4 | 21 | 36 | 187 |
1/23/13 06:02 | 1/22/13 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -16 | 1.27 | 1 | -13 | -2 | 822 | D | -38 | 24 | 36 | 11 | 10 | 17 | 8 | -2 | -1 | 1 | -9 | -10 | 25 | 164 |
12/26/12 06:28 | 12/20/12 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -15 | 1.16 | 2 | -13 | -2 | 835 | D | -51 | 14 | 30 | -11 | 22 | -7 | -5 | -4 | -2 | 8 | 13 | -1 | 22 | 123 |
11/27/12 17:10 | 11/20/12 | CUR | Health | BioPrd | Biological Products, (No Diag | Johe Karl | MD | DO | Chief Sc | S | -13 | 1.00 | 0 | -13 | -1 | 847 | D | -48 | -4 | 15 | 102 | -4 | 12 | 8 | 6 | 5 | 27 | -9 | -7 | 18 | 127 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |